CURE - Oncology & Cancer News for Patients & Caregivers
Choices About Cancer Treatment During a Tumultuous Time. September 12th 2024. In this Fall issue of CURE, we focus on AYAs with cancer, latest treatments in small cell lung cancer, preparing for a virtual visit and answering common questions about breast cancer.
Long-Term Follow-Up Shows Keytruda Continues to Improve
Feb 1, 2021 · Keytruda (pembrolizumab) continued to demonstrate a clinically meaningful improvement in overall and progression-free survival, compared with docetaxel, in patients with previously treated, PD-L1–positive advanced non-small cell lung cancer (NSCLC) after more than five years of follow-up, according to results from the phase 2/3 KEYNOTE-010 study presented at the 2020 World Conference on Lung ...
Love Lost: The Effects of Cancer on Marriage and Relationships
Oct 28, 2021 · Impact of a Cancer Diagnosis. Cancer can damage a marriage or relationship in a number of ways, counselors say. “A cancer diagnosis often has a ripple effect on how patients see themselves, on their life and on their relationships,” says Cheyenne Corbett, director of cancer support and survivorship at Duke Cancer Institute in Durham, North Carolina.
How Patients With Cancer Can Best Care For Their Chemo Port
Jun 23, 2022 · Care teams often implant a chemo port into patients with cancer to provide easy access for blood draws and to deliver treatments such as chemotherapy and antibiotics. Here, as part of its Heal at Home series, CURE® works with a …
Keytruda Has Received Nearly 40 FDA Approvals. How Does It Work?
Jan 25, 2024 · The Food and Drug Administration (FDA) recently approved Keytruda (pembrolizumab) plus chemoradiotherapy (CRT) for the treatment of patients with stages 3 to 4A cervical cancer.
The Story Behind the Pink Ribbon - Curetoday
Oct 17, 2017 · One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Pancreatic Cancer Vaccine Offers ‘New Twist’ on ... - Curetoday
Aug 29, 2024 · What’s really created all this excitement is that the phase 1 results were published in Nature Medicine in January 2024. [The vaccine] was found to be safe with … milder, common vaccine side effects, such as fever, chills and nausea.
Pluvicto Improves Survival Without Progression in Certain Patients …
Oct 23, 2023 · Pluvicto (177Lu-PSMA-617) is a radioligand therapy for metastatic castration-resistant prostate cancer (mCRPC) that met its primary end point of radiographic progression-free survival (rPFS) in a phase 3 trial. The study presented at ESMO 2023 showed a favorable safety profile and a high objective response rate for Pluvicto compared with androgen receptor pathway inhibitor (ARPI) change.
Multiple Myeloma: 8 Frequently Asked Patient Questions
Aug 27, 2024 · Multiple myeloma is a rarer disease than other cancers, such as lung or breast cancer, an expert told CURE®. During the CURE® Educated Patient® Multiple Myeloma Summit, patients asked some questions about the disease.. CURE® sat down with Dr. Brandon Blue to answer frequently asked questions about treatment options, bone strength and other comorbidities associated with multiple myeloma.
Keytruda Improves Disease-Free Survival in Advanced Bladder …
Jan 28, 2024 · Postsurgical Keytruda (pembrolizumab) tended to lengthen the time patients lived without relapse or complications from their cancer — a statistic known as “disease-free survival” (DFS) — compared to observation in patients with locally advanced urothelial carcinoma (bladder cancer), according to data from the phase 3 AMBASSADOR Alliance A031501 trial.